ArticleClinical and experimental medicine2020

Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(

Francesca Angelotti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.